Table 5.
Treatment courses
| Time from surgery to clinical presentation (weeks) | Duration of therapy (weeks) | Proportion Requiring Hospitalization | Proportion surgically treated | Average Cost | Insurance (n) | |
|---|---|---|---|---|---|---|
| Adabi 2020 [16] | – | – | – | 13/37 | $25,979 in conservative group, $15,083 in surgical | – |
| Adabi 2017 [5]* | Mean 7.2 +– 9.5 | – | 20/42 | 13/42 | $18,211 | 6 Medicaid |
| 3 Private | ||||||
| 1 Medicare | ||||||
| 1 Uninsured | ||||||
| Cai 2016 [20] | 3, 4 | 12, 24 | 2/2 | 2/2 | – | – |
| Cusumano 2017 [27] | 6, 8, 11, 12 | 38, 38, 28, 52 | – | 4/4 | – | – |
| Furuya 2008 [23] | Median 7 weeks to symptoms, 3 more weeks to presentation | Mean 24 | 5/8 | 15/19 | – | – |
| Green 2017 [22] | 12 | 44 | – | 1/1 | – | – |
| Guhan 2021 [35] | – | Mean 10 | – | 0/2 | – | – |
| Jhaveri 2020 [36] | 4 | 18 | 1/1 | 1/1 | – | – |
| Kantak 2014 [18] | 28 | – | – | 1/1 | – | – |
| Lee 2018 [17] | – | – | 4/9 | 8/9 | $98,835 | – |
| Lee 2019 [26] | 12 | 40 | – | 1/1 | – | – |
| Leto Barone 2020 [21] | 6 | 34 | 1/1 | 1/1 | – | – |
| Ross 2018 [20] | – | – | 12/78 | – | – | 48 Medicaid |
| 15 Private | ||||||
| 8 Medicare and MassHealth | ||||||
| 4 Massachusetts | ||||||
| Health Safety Net | ||||||
| 3 Uninsured | ||||||
| Schnabel 2014 [25] | – | – | 14/19 | – | – | – |
| Sharma 2016 [24] | 3 | 28 | 1/1 | 1/1 | – | – |
| Singh 2016 [8] | 3, 3, 4 | Mean 12 | – | 3/3 | – | – |
| Tran 2014 [11] | 1 | – | – | 1/1 | $77,693.50 | – |
| Venditto 2021 [14]** | – | – | 1/1 | 1/1 | $154,700.79 | 6 Private |
| 6 Medicaid | ||||||
| 4 Uninsured | ||||||
| Zheng 2019 [31] | 1–25 years | – | 1/1 | 8/10 | – | 9 Medicaid or dual Medicaid/Medicare |
| 1 Medicare | ||||||
| 1 Private | ||||||
| 1 Uninsured | ||||||
| Zhitny 2020 [28] | 2 | 8 | – | 1/1 | – | – |
*Two domestic patients included in insurance breakdown
**Details only reported on one international patient